Clinical Trials Logo

Vascular Diseases clinical trials

View clinical trials related to Vascular Diseases.

Filter by:

NCT ID: NCT00000614 Completed - Clinical trials for Cardiovascular Diseases

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Start date: September 1998
Phase: Phase 3
Study type: Interventional

A multicenter randomized, double blind placebo controlled trial to determine the efficacy of long-term, low dose warfarin in the secondary prevention of venous thromboembolism.

NCT ID: NCT00000608 Completed - Hypertension Clinical Trials

Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)

Start date: February 1997
Phase: Phase 2
Study type: Interventional

To compare the effects of three levels of dietary sodium and two patterns of diet (a control diet and an intervention diet high in fruits, vegetables, and low fat dairy products and low in fat) on blood pressure in individuals with higher than optimal blood pressure or with Stage 1 hypertension.. DASH - Sodium built on and extended the results of the NHLBI-initiated Dietary Approaches to Stop Hypertension (DASH) study.

NCT ID: NCT00000561 Completed - Clinical trials for Cardiovascular Diseases

Mode Selection Trial in Sinus Node Dysfunction (MOST)

Start date: June 1995
Phase: Phase 3
Study type: Interventional

To determine if dual chamber rate-modulated pacing (DDDR) in patients with sick sinus syndrome is superior to single chamber pacing (VVIR) with respect to subsequent frequency of adverse clinical events such as stroke, quality of life and function, and cost effectiveness.

NCT ID: NCT00000546 Completed - Hypertension Clinical Trials

Stress Reduction and Atherosclerotic CVD in Blacks

Start date: March 1994
Phase: Phase 3
Study type: Interventional

To evaluate the effectiveness of stress reduction with Transcendental Meditation (TM) on left ventricular hypertrophy, left ventricular function, blood pressure, psychosocial stress and quality of life, and cardiovascular disease risk factors.

NCT ID: NCT00000544 Completed - Hypertension Clinical Trials

Dietary Approaches to Stop Hypertension (DASH)

Start date: August 1993
Phase: Phase 3
Study type: Interventional

To test the effectiveness of dietary patterns in lowering blood pressure.

NCT ID: NCT00000543 Completed - Hypertension Clinical Trials

Oral Calcium in Pregnant Women With Hypertension

Start date: August 1993
Phase: Phase 2
Study type: Interventional

To determine of providing calcium supplementation to women with pre-existing hypertension reduces the level of blood pressure, requirement for antihypertensive drugs, and incidence of pre-eclampsia.

NCT ID: NCT00000539 Completed - Clinical trials for Cardiovascular Diseases

Arterial Disease Multifactorial Intervention Trial (ADMIT)

Start date: September 1992
Phase: Phase 3
Study type: Interventional

To evaluate, in asymptomatic and symptomatic participants with peripheral arterial disease, the feasibility of recruitment and adherence, efficacy and safety of HDL-C raising along with effective control of LDL-C levels, antioxidant therapy, antithrombotic therapy, and their combinations.

NCT ID: NCT00000537 Completed - Hypertension Clinical Trials

Stress Reduction & CVD Morbidity and Mortality in Blacks

Start date: July 1992
Phase: Phase 2
Study type: Interventional

To compare the effects of two stress reduction techniques, Transcendental Meditation (TM) and Progressive Muscle Relaxation (PMR), on the control of mild hypertension in elderly Blacks with hypertension.

NCT ID: NCT00000536 Completed - Hypertension Clinical Trials

Sodium Sensitivity in African Americans

Start date: July 1992
Phase: Phase 2
Study type: Interventional

To compare the effects of two levels of dietary sodium on blood pressure in Black men and women, and to determine what factors predict the degree of response.

NCT ID: NCT00000535 Completed - Hypertension Clinical Trials

Trial of Nonpharmacologic Interventions in Elderly (TONE)

Start date: April 1992
Phase: Phase 3
Study type: Interventional

To test the efficacy of weight loss and sodium restriction, alone and combined, in maintaining the normotensive state following withdrawal of antihypertensive medications in an elderly cohort. Conducted in collaboration with the National Institute on Aging.